Seres Therapeutics Financials
| 1S9 Stock | EUR 0.83 0.05 5.68% |
Seres |
Understanding current and past Seres Therapeutics Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Seres Therapeutics' financial statements are interrelated, with each one affecting the others. For example, an increase in Seres Therapeutics' assets may result in an increase in income on the income statement.
Seres Therapeutics Stock Summary
Seres Therapeutics competes with GUARDANT HEALTH, FEMALE HEALTH, ALEFARM BREWING, Penta Ocean, and SHIP HEALTHCARE. Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. Seres Therapeutics, Inc. was incorporated in 2010 and is headquartered in Cambridge, Massachusetts. SERES THERAPEUT operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 155 people.| Instrument | Germany Stock View All |
| Exchange | Frankfurt Exchange |
| ISIN | US81750R1023 |
| Business Address | 200 Sidney Street, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.serestherapeutics.com |
| Phone | 617 945 9626 |
| Currency | EUR - Euro |
You should never invest in Seres Therapeutics without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Seres Stock, because this is throwing your money away. Analyzing the key information contained in Seres Therapeutics' financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Seres Therapeutics Key Financial Ratios
There are many critical financial ratios that Seres Therapeutics' investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Seres Therapeutics reports annually and quarterly.Seres Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Seres Therapeutics's current stock value. Our valuation model uses many indicators to compare Seres Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Seres Therapeutics competition to find correlations between indicators driving Seres Therapeutics's intrinsic value. More Info.Seres Therapeutics is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Seres Therapeutics' earnings, one of the primary drivers of an investment's value.Seres Therapeutics Systematic Risk
Seres Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Seres Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was fourteen with a total number of output elements of fourty-seven. The Beta measures systematic risk based on how returns on Seres Therapeutics correlated with the market. If Beta is less than 0 Seres Therapeutics generally moves in the opposite direction as compared to the market. If Seres Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Seres Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Seres Therapeutics is generally in the same direction as the market. If Beta > 1 Seres Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.
Seres Therapeutics December 11, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Seres Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Seres Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Seres Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Seres Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Seres Therapeutics's daily price indicators and compare them against related drivers.
| Downside Deviation | 7.2 | |||
| Information Ratio | 0.0243 | |||
| Maximum Drawdown | 42.86 | |||
| Value At Risk | (12.50) | |||
| Potential Upside | 10.61 |
Complementary Tools for Seres Stock analysis
When running Seres Therapeutics' price analysis, check to measure Seres Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Seres Therapeutics is operating at the current time. Most of Seres Therapeutics' value examination focuses on studying past and present price action to predict the probability of Seres Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Seres Therapeutics' price. Additionally, you may evaluate how the addition of Seres Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Stocks Directory Find actively traded stocks across global markets | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |